USPTO serial 79254035
GREENHALER
Reviewed by CopyMark Law Group
Reg. 5893873Status 713
- Filing date
- Status date
- Registration date
- Oct 29, 2019
- Examiner
- WIENER, MICHAEL
- Law office
- TTAB
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with GREENHALER?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medical preparations in the nature of pharmaceuticals for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, glaucoma, nausea and vomiting, stroke, cancer, drug dependence, drug addiction, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, mental illness, and hepatic, renal, intestinal, autoimmune, metabolic, neurological, dermatological and cardiovascular disorders; sanitary preparations for medical purposes; vaccines; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations for injection for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; drug delivery agents in the form of liquid medications, tablets, powders, capsules, inhalers, nasal sprays, orally disintegrating tablets, mouthwashes, that facilitate the delivery of pharmaceutical preparations; medicated transdermal drug delivery patches for use in the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders | SECTION 18 - CANCELLED | — |
| 010 | Inhalers for medical purposes; filters for inhalers for medical purposes; inhalers for medical use; inhalers for therapeutic use; drug delivery systems; medical apparatus and units for dosage, measuring and monitoring, namely, drug delivery devices and systems; microneedle arrays for delivering medications; hypodermic syringes for injections for medical purposes; non-medicated transdermal drug delivery patches; medical apparatus and instruments for the treatment of pain, asthma, chronic obstructive pulmonary disease (copd), bronchitis, emphysema, epilepsy, anxiety, depression, Parkinson's disease, Huntington's diseases, amyotrophic lateral sclerosis, nausea, stroke, cancer, drug dependence, glaucoma, autoimmune uveitis, bacterial and fungal infections, osteoporosis, sepsis, and hepatic, renal, intestinal and cardiovascular disorders; medical apparatus and instruments for use in surgery | SECTION 18 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 11, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Aug 17, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Aug 17, 2023 | INPC | INVALIDATION PROCESSED | — |
| Jul 18, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Nov 18, 2022 | C18. | CANCELLED SECTION 18-TOTAL | — |
| Nov 18, 2022 | CANT | CANCELLATION TERMINATED NO. 999999 | — |
| Aug 25, 2022 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| Mar 29, 2022 | CANG | CANCELLATION GRANTED NO. 999999 | — |
| Dec 21, 2021 | PETC | CANCELLATION INSTITUTED NO. 999999 | — |
| Mar 13, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 24, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 24, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 29, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 29, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 23, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 13, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 13, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 7, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 7, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 24, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 8, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 1, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 1, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 28, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 21, 2019 | ALIE | ASSIGNED TO LIE | — |
| Jun 17, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 8, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 24, 2019 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| May 22, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 22, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 29, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 28, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 16, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 19, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 15, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 14, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |